Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | Morningstar
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
BioNTech (BNTX) Expected to Release Quarterly Earnings on Tuesday
Expanded mRNA Patent Suits Against Pfizer Involving BioNTech's LNP Technology Might Change The Case For Investing In BioNTech (BNTX)
Hsbc Holdings PLC Sells 31,445 Shares of BioNTech SE Sponsored ADR $BNTX
BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes Build
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by Brokerages
Aristides Capital LLC Decreases Holdings in BioNTech SE Sponsored ADR $BNTX
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
SEB Asset Management AB Buys Shares of 200,108 BioNTech SE Sponsored ADR $BNTX - Zolmax
SEB Asset Management AB Buys New Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily
BioNTech SE Sponsored ADR $BNTX Shares Sold by Baader Bank Aktiengesellschaft
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Analysts
BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen - Markets Daily
BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?
BioNTech (NASDAQ:BNTX) Rating Increased to Hold at Wall Street Zen - Daily Political
BioNTech (NASDAQ:BNTX) Upgraded to Hold at Wall Street Zen
How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech - Update | Morningstar
BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center
Pfizer vaccine generates strong immune response in children under 5
Pfizer says vaccine is 100% effective in protecting adolescents
Candriam S.C.A. Lowers Holdings in BioNTech SE Sponsored ADR $BNTX
BioNTech (BNTX) Could Be 82% Undervalued On Its Manufacturing Reset
BioNTech (BNTX) Stock Could Be Overvalued After a 58% Five Year Slump
Hsbc Holdings PLC Makes New $4.97 Million Investment in BioNTech SE Sponsored ADR $BNTX - Markets Daily
Cathie Wood Buys More SpaceX, Sells AMD, BioNTech, and Other Growth Stocks, 7/9/26
BioNTech and Pfizer secure big European win over mRNA patent
10 Newly Overvalued Stocks this Week | Morningstar
BioNTech (BNTX) Is Up 6.9% After Moving To Exit German Manufacturing Sites Has The Bull Case Changed?
Pictet Asset Management Holding SA Boosts Stake in BioNTech SE Sponsored ADR $BNTX
BioNTech in Talks to Sell German Sites Amid Planned Closures, ETPharma
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
mRNA Cancer Vaccine Market to Surpass $1.20 Billion in 2026 as Personalized Oncology Immunotherapies Advance, New Report Finds
BioNTech news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
